Similares a REACH Study: Broncho-Vaxom (OM-85) Cuts Recurrent Respiratory Tract Infections

20 vecinos (text_768) · 134 views · HCPLive · Estados Unidos


★	REACH Study: Broncho-Vaxom (OM-85) Cuts Recurrent Respiratory Tract Infections	HCPLive @hcplivenews	134	Estados Unidos
18	Bronchitis verstehen: Ursachen, Symptome, Diagnose & Therapie \| DocTommy	Die Techniker @technikerkrankenkasse	79.7K	Alemania	85
11	RCT: Azelastine Nasal Spray Reduces COVID by 67%	MedCram - Medical Lectures Explained CLEARLY @medcram	41.8K	Estados Unidos	85
13	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	85
17	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	85
5	La UC estudia del impacto de la contaminación sobre la salud respiratoria de poblaciones vulnerables	UNIversidadCANtabria @universidadcantabria	499	España	85
7	La Universitat se suma al Dia Europeu de Dèficit d'Alfa-1	Universitat de València @universitatvalencia	481	España	85
1	What #Allergists Should Know About Broncho-Vaxom for Respiratory Tract Infection	HCPLive @hcplivenews	348	Estados Unidos	95
15	Avances terapéuticos en Hipertensión Pulmonar y su impacto en pacientes con comorbilidades	FAC @fac_cardio	209	Argentina	85
16	AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	129	Estados Unidos	85
8	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	85
4	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	85
14	Brensocatib, 1 Year Later: Who Benefits Most? \| Mark Metersky, MD	HCPLive @hcplivenews	98	Estados Unidos	85
10	ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	70	Estados Unidos	85
12	Robert Wood, MD, on Age, Dosing in Multifood Allergy OIT	HCPLive @hcplivenews	70	Estados Unidos	85
9	Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients \| ATS 2026	HCPLive @hcplivenews	68	Estados Unidos	85
6	Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More \| EAC 2026	HCPLive @hcplivenews	58	Estados Unidos	85
2	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	86
19	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	85
3	Clearing the Airway: Physiotherapy Approaches to Combat Popcorn Lung in Vape Users	MAHSA University @mahsaedu	35	—	86
20	Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges	ReachMD @reachmd	7	Estados Unidos	85